| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |